Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3025 of 3284 entries
View as:

An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03924635 Org: User:
Start: 08/01/19 End: 12/16/22 Due: 12/16/23

A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD8683 When Administered in Different Ways

Phase: N/A Priority: Normal
NCT ID: NCT01666613 Org: User:
Start: 11/30/12 End: 03/31/13 Due: 03/31/14

A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT04483947 Org: User:
Start: 11/06/20 End: 12/18/23 Due: 12/18/24

Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec

Phase: N/A Priority: Normal
NCT ID: NCT01116271 Org: User:
Start: 04/30/10 End: 07/31/12 Due: 07/31/13

Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00789854 Org: User:
Start: 11/30/08 End: 08/31/09 Due: 08/31/10

Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand

Phase: N/A Priority: Normal
NCT ID: NCT00800241 Org: User:
Start: 05/31/09 End: 11/30/09 Due: 11/30/10

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US

Phase: N/A Priority: Normal
NCT ID: NCT00795093 Org: User:
Start: 11/30/08 End: 01/31/10 Due: 01/31/11

Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT00637845 Org: User:
Start: 06/30/02 End: 02/28/03 Due: 02/28/04

ICS/LABA Adherence and COPD Exacerbation

Phase: N/A Priority: Normal
NCT ID: NCT02446041 Org: User:
Start: 05/31/15 End: 10/31/15 Due: 10/31/16

Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT02252224 Org: User:
Start: 09/23/14 End: 11/30/16 Due: 11/30/17

Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00766012 Org: User:
Start: 09/30/08 End: 07/31/09 Due: 07/31/10

Asthma Comparative Effectiveness Study

Phase: N/A Priority: Normal
NCT ID: NCT01623544 Org: User:
Start: 06/30/12 End: 09/30/12 Due: 09/30/13

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT03205176 Org: User:
Start: 06/30/17 End: 04/08/21 Due: 04/08/22

Prevalence of Asthma and Allergies Among Children in UAE

Phase: N/A Priority: Normal
NCT ID: NCT03878680 Org: User:
Start: 04/30/19 End: 06/26/19 Due: 06/26/20

IBS-C Questionnaire Study

Phase: N/A Priority: Normal
NCT ID: NCT04968652 Org: User:
Start: 11/01/21 End: 10/28/22 Due: 10/28/23

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00229658 Org: User:
Start: 09/30/05 End: 05/31/08 Due: 05/31/09

A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00713544 Org: User:
Start: 07/31/08 End: 04/30/09 Due: 04/30/10

Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT01432392 Org: User:
Start: 09/30/11 End: 04/30/12 Due: 04/30/13

Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study

Phase: N/A Priority: Normal
NCT ID: NCT05697705 Org: User:
Start: 07/22/22 End: 05/18/23 Due: 05/18/24

Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT00402259 Org: User:
Start: 08/31/06 End: 10/31/07 Due: 10/31/08

Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00842556 Org: User:
Start: 03/31/09 End: 05/31/09 Due: 05/31/10

A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04931654 Org: User:
Start: 09/28/21 End: 08/12/26 Due: 08/12/27

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT06542250 Org: User:
Start: 09/18/24 End: 02/14/28 Due: 02/14/29

(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00673205 Org: User:
Start: 09/30/95 End: 08/31/08 Due: 08/31/09

Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT03022097 Org: User:
Start: 02/02/17 End: 04/14/22 Due: 04/14/23